Combined Effect of Natural Killer Cell and Doublet Chemotherapy in Advanced NSCLC as the 1st Line Treatment
Clinical trial NCT02370017 · UNKNOWN
Trial details
- NCT number
- NCT02370017
- Sponsor
- The Catholic University of Korea
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2018-08-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.